Sight Sciences Inc. has announced a corporate reorganization aimed at reducing operating expenses and improving cost efficiencies as part of a strategic plan for long-term growth. The company will reduce its workforce by 20%, affecting 43 employees, and will delay certain research and development projects while prioritizing near-term pipeline projects. Operating expenses will be reduced by cutting marketing, travel, and administrative costs, and by not backfilling certain open positions. The reorganization is expected to save approximately $11.9 million annually. Additionally, the company will incur a cash restructuring charge of $2.7 million to $3.0 million primarily for employee severance and benefits. Sight Sciences reaffirms its revenue guidance for 2025 at $72 million to $76 million, despite the expected mid-single-digit decline in third-quarter surgical glaucoma revenue compared to the previous year. The reorganization includes proposed changes in the UK, subject to compliance with local regulations.